(Q37031463)

17 August 2017

1 reference

title

Prognosis of polymyalgia rheumatica and giant cell arteritis (English)

1 reference

17 August 2017

main subject

polymyalgia rheumatica

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80068-8

30 November 2022

author name string

A. B. Myles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1807824

30 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1807824

30 November 2022

publication date

1 December 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:S0950357905800688?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80068-8

https://api.elsevier.com/content/article/PII:S0950357905800688?httpAccept=text/plain

30 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80068-8

Bailliere's clinical rheumatology

30 November 2022

published in

1 reference

17 August 2017

volume

5

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

493-503

1 reference

Temporal artery biopsy and corticosteroid treatment

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Osteoporosis after long-term corticosteroid treatment of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Polymyalgia rheumatica. Duration of therapy and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Prognosis in the anarthritic rheumatoid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Myalgic syndrome with constitutional effects; polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Polymyalgia rheumatica and corticosteroids: how much for how long?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Clinical and biopsy findings in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Prevalence of hypothyroidism in patients with polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Senile Rheumatic Gout

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

A prospective study of 102 patients with the polymyalgia rheumatica syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Temporal arteritis; review of the literature and report of five additional cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Occult temporal arteritis. A common cause of blindness in old age

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Temporal arteritis. Occurrence of ocular complications 7 years after diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Ophthalmic complications of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Autoimmune thyroid disease and the polymyalgia rheumatica-giant cell arteritis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Giant cell arteritis: loss of vision during corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Prolonged corticosteroid treatment in the management of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Prognosis in giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

The therapeutic impact of temporal artery biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Temporal arteritis--progressive affection of vision during high-level corticosteroid therapy. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Prognosis and management of polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Large Artery Involvement in Giant Cell (Temporal) Arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Stopping steroids in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Temporal arteritis in blacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

The clinical neuro-ophthalmologic spectrum of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Polymyalgia rheumatica and giant cell arteritis: a seven-year survey

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Neurologic manifestations of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Giant cell arteritis as a cause of death. Report of nine cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Clinical usefulness of temporal artery biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Temporal arteritis and its treatment with cortisone and A.C.T.H.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

1 reference

7 January 2021

Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980068-8

7 January 2021

Ocular involvement in giant cell arteritis

18

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80068-8

Cranial arteritis. A preventable cause of blindness

30 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80068-8

Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis

30 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80068-8

Prevention of blindness in giant cell arteritis by corticosteroid treatment

30 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80068-8

Nonclassical organ involvement in temporal arteritis

30 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80068-8

Treatment and prognosis in polymyalgia rheumatica and temporal arteritis. A ten-year survey of 53 patients

30 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80068-8

30 November 2022

Identifiers

1 reference

release_gwuf223iojdvvmme65ztplutyy

17 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gwuf223iojdvvmme65ztplutyy

24 November 2022

mapped directly with Wikidata item

1 reference